<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR99.html">Part 99
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 99.301  Agency action on a submission.
                            </h3>
                            <p class="depth1"><em>(a)</em> Submissions. Within 60 days after receiving a submission under  this part, FDA may:</p><p class="depth2"><em>(1)</em> Determine that the manufacturer does not comply with the  requirements under this part and that, as a result, the manufacturer  shall not disseminate any information under this part;</p><p class="depth2"><em>(2)</em> After providing the manufacturer notice and an opportunity for a  meeting, determine that the information submitted regarding a new use  fails to provide data, analyses, or other written matter that is  objective and balanced and:</p><p class="depth3"><em>(i)</em> Require the manufacturer to disseminate additional information,  including information that the manufacturer has submitted to FDA or,  where appropriate, a summary of such information or any other  information that can be made publicly available, which, in the agency's  opinion:</p><p class="depth4"><em>(A)</em> Is objective and scientifically sound;</p><p class="depth4"><em>(B)</em> Pertains to the safety or effectiveness of the new use; and</p><p class="depth4"><em>(C)</em> Is necessary to provide objectivity and balance; and</p><p class="depth3"><em>(ii)</em> Require the manufacturer to disseminate an objective statement  prepared by FDA that is based on data or other scientifically sound  information available to the agency and bears on the safety or  effectiveness of the drug or device for the new use; and</p><p class="depth2"><em>(3)</em> Require the manufacturer to maintain records that will identify  individual recipients of the information that is to be disseminated when  such individual records are warranted due to special safety  considerations associated with the new use.</p><p class="depth1"><em>(b)</em> Protocols/Studies. Within 60 days after receiving a submission  under this part, FDA shall:</p><p class="depth2"><em>(1)</em> If the manufacturer has planned studies that will be needed for  the submission of a supplemental application for the new use, review the  manufacturer's proposed protocols and schedule for completing such  studies and determine whether the proposed protocols are adequate and  whether the proposed schedule for completing the studies is reasonable.  FDA shall notify the manufacturer of its determination; or</p><p class="depth2"><em>(2)</em> If the manufacturer has completed studies that the manufacturer  believes would be an adequate basis for the submission of a supplemental  application for the new use, conduct a review of the protocols submitted  for such studies to determine whether they are adequate. FDA shall  notify the manufacturer of its determination.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
